28 January 2025
28 January 2025
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of shareholders.
If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.
GSK has committed to invest up to $62.3m over at least three years.
This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.
The therapy treats primary monogenic IL-18-driven hyperinflammatory syndrome, a rare paediatric condition.
The move will leverage Microsoft's AI cloud capabilities to speed up the detection of targets.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
